Atlas Trials

Provenge Followed by Docetaxel in Castration-Resistant Prostate Cancer

Clinical trial NCT02793219 · WITHDRAWN

Trial details

NCT number
NCT02793219
Sponsor
The University of Texas Health Science Center, Houston
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2016-12-01
Primary completion
2018-07-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.